Viking Global Performance Llc - Net Worth and Insider Trading
Viking Global Performance Llc Net Worth
The estimated net worth of Viking Global Performance Llc is at least $3.3 Billion dollars as of 2024-11-10. Viking Global Performance Llc is the 10% Owner of Myovant Sciences Ltd and owns about 40,765,599 shares of Myovant Sciences Ltd (MYOV) stock worth over $1.1 Billion. Viking Global Performance Llc is the 10% Owner of Roivant Sciences Ltd and owns about 75,238,700 shares of Roivant Sciences Ltd (ROIV) stock worth over $893 Million. Viking Global Performance Llc is also the 10% Owner of BridgeBio Pharma Inc and owns about 26,620,991 shares of BridgeBio Pharma Inc (BBIO) stock worth over $721 Million. Besides these, Viking Global Performance Llc also holds Urovant Sciences Ltd (UROV) , Adaptive Biotechnologies Corp (ADPT) , Sio Gene Therapies Inc (SIOX) . Details can be seen in Viking Global Performance Llc's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Viking Global Performance Llc has not made any transactions after 2023-06-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Viking Global Performance Llc
Viking Global Performance Llc Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Viking Global Performance Llc owns 11 companies in total, including Adaptive Biotechnologies Corp (ADPT) , Arbutus Biopharma Corp (ABUS) , and Sio Gene Therapies Inc (SIOX) among others .
Click here to see the complete history of Viking Global Performance Llc’s form 4 insider trades.
Insider Ownership Summary of Viking Global Performance Llc
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ADPT | Adaptive Biotechnologies Corp | 2020-11-11 | 10 percent owner |
ABUS | Arbutus Biopharma Corp | 2016-07-08 | 10 percent owner |
SIOX | Sio Gene Therapies Inc | 2019-03-18 | 10 percent owner |
2019-06-04 | 10 percent owner | ||
2019-07-10 | other: Former 10% Owner | ||
2019-06-27 | 10 percent owner | ||
2016-04-13 | 10 percent owner | ||
2016-02-08 | 10 percent owner | ||
2014-10-01 | 10 percent owner | ||
2023-06-22 | 10 percent owner | ||
2022-01-03 | 10 percent owner |
Viking Global Performance Llc Latest Holdings Summary
Viking Global Performance Llc currently owns a total of 6 stocks. Among these stocks, Viking Global Performance Llc owns 40,765,599 shares of Myovant Sciences Ltd (MYOV) as of June 4, 2019, with a value of $1.1 Billion and a weighting of 33.61%. Viking Global Performance Llc owns 75,238,700 shares of Roivant Sciences Ltd (ROIV) as of June 22, 2023, with a value of $893 Million and a weighting of 27.29%. Viking Global Performance Llc also owns 26,620,991 shares of BridgeBio Pharma Inc (BBIO) as of June 27, 2019, with a value of $721 Million and a weighting of 22.04%. The other 3 stocks Urovant Sciences Ltd (UROV) , Adaptive Biotechnologies Corp (ADPT) , Sio Gene Therapies Inc (SIOX) have a combined weighting of 17.05% among all his current holdings.
Latest Holdings of Viking Global Performance Llc
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
MYOV | Myovant Sciences Ltd | 2019-06-04 | 40,765,599 | 26.98 | 1,099,855,861 |
ROIV | Roivant Sciences Ltd | 2023-06-22 | 75,238,700 | 11.87 | 893,083,369 |
BBIO | BridgeBio Pharma Inc | 2019-06-27 | 26,620,991 | 27.09 | 721,162,646 |
UROV | Urovant Sciences Ltd | 2019-06-19 | 22,860,013 | 16.24 | 371,246,611 |
ADPT | Adaptive Biotechnologies Corp | 2020-11-11 | 30,993,708 | 5.82 | 180,383,381 |
SIOX | Sio Gene Therapies Inc | 2019-03-18 | 13,244,048 | 0.48 | 6,330,655 |
Holding Weightings of Viking Global Performance Llc
Viking Global Performance Llc Form 4 Trading Tracker
According to the SEC Form 4 filings, Viking Global Performance Llc has made a total of 0 transactions in Myovant Sciences Ltd (MYOV) over the past 5 years. The most-recent trade in Myovant Sciences Ltd is the acquisition of 2,424,242 shares on June 4, 2019, which cost Viking Global Performance Llc around $20 Million.
According to the SEC Form 4 filings, Viking Global Performance Llc has made a total of 1 transactions in Roivant Sciences Ltd (ROIV) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Roivant Sciences Ltd is the sale of 13,000,000 shares on June 22, 2023, which brought Viking Global Performance Llc around $129 Million.
According to the SEC Form 4 filings, Viking Global Performance Llc has made a total of 0 transactions in BridgeBio Pharma Inc (BBIO) over the past 5 years. The most-recent trade in BridgeBio Pharma Inc is the acquisition of 4,705,900 shares on June 27, 2019, which cost Viking Global Performance Llc around $80 Million.
More details on Viking Global Performance Llc's insider transactions can be found in the Insider Trading History of Viking Global Performance Llc table.Insider Trading History of Viking Global Performance Llc
- 1
Viking Global Performance Llc Trading Performance
GuruFocus tracks the stock performance after each of Viking Global Performance Llc's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Viking Global Performance Llc is 1.57%. GuruFocus also compares Viking Global Performance Llc's trading performance to market benchmark return within the same time period. The performance of stocks bought by Viking Global Performance Llc within 3 months outperforms 9 times out of 16 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Viking Global Performance Llc's insider trading performs compared to the benchmark.
Performance of Viking Global Performance Llc
Viking Global Performance Llc Ownership Network
Ownership Network List of Viking Global Performance Llc
Ownership Network Relation of Viking Global Performance Llc
Viking Global Performance Llc Owned Company Details
What does Adaptive Biotechnologies Corp do?
Who are the key executives at Adaptive Biotechnologies Corp?
Viking Global Performance Llc is the 10 percent owner of Adaptive Biotechnologies Corp. Other key executives at Adaptive Biotechnologies Corp include SVP and General Counsel Stacy L Taylor , Chief Financial Officer Tycho Peterson , and Principal Accounting Officer Kyle Piskel .
Adaptive Biotechnologies Corp (ADPT) Insider Trades Summary
Over the past 18 months, Viking Global Performance Llc made no insider transaction in Adaptive Biotechnologies Corp (ADPT). Other recent insider transactions involving Adaptive Biotechnologies Corp (ADPT) include a net sale of 258,417 shares made by Tycho Peterson , a net sale of 40,303 shares made by Stacy L Taylor , and a net sale of 7,986 shares made by Kyle Piskel .
In summary, during the past 3 months, insiders sold 26,922 shares of Adaptive Biotechnologies Corp (ADPT) in total and bought 0 shares, with a net sale of 26,922 shares. During the past 18 months, 467,732 shares of Adaptive Biotechnologies Corp (ADPT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 467,732 shares.
Adaptive Biotechnologies Corp (ADPT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adaptive Biotechnologies Corp Insider Transactions
Viking Global Performance Llc Mailing Address
Above is the net worth, insider trading, and ownership report for Viking Global Performance Llc. You might contact Viking Global Performance Llc via mailing address: 55 Railroad Avenue, 3rd Floor, Greenwich Ct 06830.